Thompson Davis & Co., Inc. Karyopharm Therapeutics Inc. Transaction History
Thompson Davis & Co., Inc.
- $124 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding KPTI
# of Institutions
7Shares Held
4.71MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.17MShares$17.9 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA324KShares$1.39 Million0.24% of portfolio
-
Jefferies Group LLC New York, NY102KShares$437,3100.01% of portfolio
-
Wade G W & Inc Wellesley, MA45.1KShares$194,1020.0% of portfolio
-
Sawtooth Solutions, LLC37.9KShares$163,1330.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $343M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...